Alexandre Prat
Impact in
- Neurology top 0.02%
- Barrier Structure and Function Studies
- Neuroinflammation and Neurodegeneration Mechanisms
- Pathology and Forensic Medicine top 0.02%
- Multiple Sclerosis Research Studies
Papers in
-
- Multiple Sclerosis Research Studies 236
- Neurology 76
- Barrier Structure and Function Studies 56
- Neuroinflammation and Neurodegeneration Mechanisms 23
- Co-authors
- Jack Perry Antel (51 shared papers)Jorge Ivan Alvarez (30 shared papers)Hania Kébir (26 shared papers)Romain Cayrol (16 shared papers)Nathalie Arbour (38 shared papers)Igal Ifergan (21 shared papers)Burkhard Becher (11 shared papers)Aurore Dodelet-Devillers (11 shared papers)
- Journals
- Multiple Sclerosis Journal (28 papers)Brain (17 papers)Neurology (14 papers)Multiple Sclerosis and Related Disorders (11 papers)Neurology Neuroimmunology & Neuroinflammation (10 papers)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
Alexandre Prat
308 papers receiving 22.1k citations
Alexandre Prat's Hit Papers
Peers
Comparison fields: 5 of 134
- Neurology 5.1k
- Pathology and Forensic Medicine 9.3k
- Biological Psychiatry 366
- Immunology 1.9k
- Developmental Neuroscience 268
Countries citing papers authored by Alexandre Prat
This map shows the geographic impact of Alexandre Prat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Prat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Prat more than expected).
Fields of papers citing papers by Alexandre Prat
This network shows the impact of papers produced by Alexandre Prat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Prat. The network helps show where Alexandre Prat may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexandre Prat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 330 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation Hit paper breakdown → | 2007 | 1466 |
| 2 | Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor Hit paper breakdown → | 2016 | 1284 |
| 3 | The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence Hit paper breakdown → | 2011 | 711 |
| 4 | An updated histological classification system for multiple sclerosis lesions Hit paper breakdown → | 2016 | 536 |
| 5 | Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis Hit paper breakdown → | 2009 | 468 |
| 6 | 2013 | 455 | |
| 7 | Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39 Hit paper breakdown → | 2019 | 447 |
| 8 | Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation Hit paper breakdown → | 2014 | 415 |
| 9 | Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis Hit paper breakdown → | 2019 | 414 |
| 10 | MAFG-driven astrocytes promote CNS inflammation Hit paper breakdown → | 2020 | 381 |
| 11 | Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy Hit paper breakdown → | 2015 | 380 |
| 12 | 2007 | 356 | |
| 13 | Defining secondary progressive multiple sclerosis Hit paper breakdown → | 2016 | 350 |
| 14 | Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study Hit paper breakdown → | 2020 | 344 |
| 15 | 2011 | 318 | |
| 16 | Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10 Hit paper breakdown → | 2019 | 311 |
| 17 | 2000 | 299 | |
| 18 | 2010 | 287 | |
| 19 | 2001 | 275 | |
| 20 | Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes Hit paper breakdown → | 2021 | 265 |
About Alexandre Prat
Alexandre Prat is a scholar working on Pathology and Forensic Medicine, Neurology, Immunology, Immunology and Allergy and Cellular and Molecular Neuroscience, having authored 330 papers that have together received 22.6k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (236 papers), Barrier Structure and Function Studies (56 papers), Neuroinflammation and Neurodegeneration Mechanisms (23 papers), Cell Adhesion Molecules Research (9 papers), T-cell and B-cell Immunology (7 papers), Neuropeptides and Animal Physiology (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). The work is most often cited by research in Neurology (5.1k citations), Pathology and Forensic Medicine (9.3k citations), Biological Psychiatry (366 citations), Immunology (1.9k citations) and Developmental Neuroscience (268 citations). Alexandre Prat has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Jack Perry Antel, Jorge Ivan Alvarez, Hania Kébir, Romain Cayrol, Nathalie Arbour, Igal Ifergan, Burkhard Becher, Aurore Dodelet-Devillers, Catherine Larochelle and Karolina Wosik. Their work appears in journals such as Multiple Sclerosis Journal, Brain, Neurology, Multiple Sclerosis and Related Disorders and Neurology Neuroimmunology & Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.